Beyond dispensing: rethinking the pharmacist’s role in telemedicine

Article information

Korean J Intern Med. 2026;41(6):1153-1154
Publication date (electronic) : 2026 November 1
doi : https://doi.org/10.3904/kjim.2026.161
1Department of Pharmacy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Pharmacy, Quzhou People’s Hospital; The Quzhou Affiliated Hospital, Wenzhou Medical University, Quzhou, China
Correspondence to: Kai-Li Mao, MD, Department of Pharmacy, Quzhou People’s Hospital; The Quzhou Affiliated Hospital, Wenzhou Medical University, No.100 Minjiang Avenue, Quzhou 324000, China, Tel: +86-5703125020, E-mail: 1258371506@wmu.edu.cn, https://orcid.org/0009-0001-1556-4365
Received 2026 March 31; Revised 2026 May 9; Accepted 2026 May 28.

Dear Editor,

We read with great interest the article by Jung et al. [1] on pharmacists in telemedicine experiences. Pharmacists are now central to healthcare delivery, demonstrating irreplaceable value across diverse clinical and therapeutic fields [2–4]. We here highlight the challenges and research priorities.

TELEMEDICINE MARGINALIZATION AND PHARMACISTS’ PROFESSIONAL IDENTITY UNCERTAINTY

Jung et al. [1] found that pharmacists reported lower participation intention (67.0% vs. 84.7% for doctors). This may reflect telemedicine’s historical doctor-patient focus, which marginalizes pharmacists; limited prior experience and unclear role definitions are alternative explanations. Pharmacists prioritized chronic disease management, whereas doctors cited patient demand, suggesting a misalignment between pharmacists’ expectations and system design. As Jung et al. did not measure frustration or system support, these interpretations remain speculative.

Our analysis must be interpreted within Korea’s legal framework. The separation of prescribing and dispensing limits pharmacists’ independent clinical decision-making. Our proposed “online immediate response” does not imply autonomous prescribing or diagnosis, but structured medication counseling, adherence support, and adverse-effect screening, all requiring a valid prescription. AI-driven automated dispensing without pharmacist verification, or independent triage leading to dispensing, is not permitted under the Pharmacy and Medical Service Act. Our model therefore presupposes legal reforms or pilot exceptions.

TELEPHARMACY PRACTICE MODEL

Jung et al. reported 24% of cosmetic/hair-loss consultations lasted ≤3 minutes, suggesting overtreatment risk. We add that pharmacists’ exclusion causes counseling gaps, and such brevity may still demand extensive behind-the-scenes work, increasing burnout risk.

We propose a three-tiered integrated pharmacy practice model. Tier 1: online immediate response for real-time triage and structured counseling, enabled asynchronously after brief telemedicine encounters. Tier 2: risk-stratified referrals to physical clinics for comprehensive medication management, triggered by consultation brevity or polypharmacy rather than schedules. Tier 3: telepharmacy bridge services ensuring continuity across hospital and community settings, requiring inter-pharmacy information sharing and follow-up documentation, transforming pharmacists from episodic dispensers into continuous care coordinators. This hypothesis-generating model lacks pilot evidence; feasibility should be tested via pharmacist acceptance, referral completion, and error detection, enabled by shared records and handoffs under regulatory pilots.

TOWARD PROSPECTIVE STUDIES AND TECHNOLOGY-INTEGRATED PHARMACY PRACTICE

Telepharmacy’s effect on medication errors is unclear. Telepharmacy may reduce errors through reconciliation and monitoring, but may also create “digital errors” from communication constraints, technological failures, or workflow disruptions. Brief consultations (≤3 minutes) suggest counseling gaps, requiring prospective trials and broader error classifications. AI and 5G could support pharmacists, but AI-driven dispensing or autonomous triage remains legally impermissible in Korea; our recommendation is long-term and contingent on legal reform and pharmacist oversight.

FROM FEE-FOR-SERVICE TO VALUE-BASED TELEMEDICINE

Pharmacists’ telemedicine roles depend on payment reform: fee-for-service rewards volume, whereas value-based models need robust outcome measures. As 28.6% of pharmacists fear platform competition, Korea should first launch legal pilot programs defining permitted telepharmacy activities, temporarily waive delivery restrictions, and evaluate safety outcomes before full implementation.

Notes

CRedit authorship contributions

Liu-Cheng Li: writing - original draft, writing - review & editing; Yan Guan: writing - review & editing; Kai-Li Mao: writing - original draft, writing - review & editing

Conflicts of interest

The authors disclose no conflicts.

Funding

None

References

1. Jung Y, Kim H, Kim JY, et al. Analysis of experiences on telemedicine pilot projects from the perspectives of doctors, pharmacists, and patients. Korean J Intern Med 2026;41:131–142.
2. Li LC, Sun W, Lv XQ, Xu YY, Hu Y, Shi JN. Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature. Front Cardiovasc Med 2024;10:1133662.
3. Li LC, Zhang ZH, Chen MM, Xu F, Mao KL. Bleeding and antiplatelet therapies: a combined pharmacovigilance analysis of the FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report databases, and the role of pharmacists. Int J Surg 2026;112:3612–3624.
4. Wang C, Li LC, Ying J, Chen Q, Mao KL, Kan LD. Characteristics of online medication consultation from home-based patients on a tertiary hospital WeChat platform: a cross-sectional study. Int J Med Inform 2026;210:106308.

Article information Continued